Bone Biologics (BBLG) Other Operating Expenses (2010 - 2017)
Bone Biologics (BBLG) posted quarterly Other Operating Expenses of $119209.0 for Q1 2025, up 103.38% quarter-over-quarter from -$3.5 million in Q2 2017.
Powered by 
Analysis
Bone Biologics (BBLG) Other Operating Expenses (2010 - 2017) Analysis & Trends
Bone Biologics (BBLG) has reported Other Operating Expenses for 8 consecutive years, with $119209.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Other Operating Expenses changed N/A year-over-year to $119209.0; the TTM figure through Dec 2025 stood at $119209.0 (changed N/A YoY), while the FY2017 annual figure was -$2.7 million, down 56353.09% from the prior year.
- Other Operating Expenses grew to $119209.0 in Q1 2025 per BBLG's latest filing, from -$3.5 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $119209.0 in Q1 2025 and bottomed at $119209.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2017 | -3.53 Mn |
| Mar 31, 2017 | 784,525.00 |
| Mar 31, 2016 | -4,862.00 |
| Sep 30, 2014 | 877,776.00 |
| Dec 31, 2013 | 668,209.00 |
| Oct 31, 2013 | 582.00 |
| Jul 31, 2013 | 1,055.00 |
| Apr 30, 2013 | 1,043.00 |
| Jan 31, 2013 | 1,588.00 |
| Jul 31, 2012 | 1,088.00 |
| Apr 30, 2012 | 1,750.00 |
| Jan 31, 2012 | 1,356.00 |
| Oct 31, 2011 | 1,718.00 |
| Jul 31, 2011 | 725.00 |
| Oct 31, 2010 | 710.00 |